Trial Details
RECRUITINGBasic Information
| Clinical ID | c68 |
|---|---|
| Identifier | NCT07235904 |
| Trial Title | Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: Mirikizumab|DRUG: Azathioprine (AZA) |
Participant Information
| Sponsor | University Hospital Schleswig-Holstein |
|---|---|
| City | Kiel |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-12-05 |
|---|---|
| Primary Completion Date | 2028-03 |
| Completion Date | 2028-10 |